CANDIDATEZ AU PROGRAMME D'ACCÉLÉRATION SANTÉ

Fermer définitivement
Close menu

 

  • New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidates
  • Evotec’s human stem cell-based platform enables better-informed decisions regarding which drug candidates to advance into clinical testing
  • Continued collaboration underscores Evotec’s capabilities in advanced human cell-based drug discovery technologies

    Read the press release

More information